Osteopathy Treatment and Cardiovascular Recovery After a Rugby Match

January 22, 2020 updated by: Elena Giovanna Bignami, University of Parma

Osteopathy Treatment Restores Cardiovascular Autonomic Parameters in Rugby Players

The purpose of this study was to explore the efficacy of osteopathic manipulative treatment (OMT), a form of non-invasive manual treatment, for a faster recovery of cardiovascular parameters after a rugby union match in professional male athletes. To this end, the effects of OMT on resting cardiovascular function and cardiovascular reactivity were evaluated in twenty-three male players 18-20 hours after a match and compared with a corresponding no-match (control) condition. Assessment of resting cardiovascular parameters 18-20 hours after a match revealed the presence of elevated mean arterial pressure and heart rate, and reduced vagally-mediated heart rate variability compared with a no-match condition. OMT provoked a significant reduction in mean arterial pressure and increased vagally-mediated heart rate variability at rest both in the after match and control conditions. Moreover, OMT favoured a larger vagal withdrawal in response to an orthostatic stress compared with a sham treatment. These results suggest that OMT may be implemented as a recovery strategy to restore athletes' cardiovascular homeostasis after a rugby union match.

Study Overview

Detailed Description

The presence of cardiovascular autonomic alterations in the aftermath of an intense exercise performed during a competitive match may indicate incomplete recovery and prolonged fatigue.Therefore, the implementation of effective interventions aimed at favoring a faster recovery of athletes' cardiovascular homeostasis in the aftermath of a competitive match may be beneficial for greater adaptations to subsequent training and enhanced overall performance. In this regard, osteopathic manipulative treatment (OMT) is a form of non-invasive manual treatment that uses a set of touch, manipulation and mobilization procedures to diagnose, treat, and prevent illness or injury. In the present study, the investigators sought to explore the efficacy of a single session of OMT in restoring alterations in cardiovascular parameters at rest and in response to an orthostatic challenge in trained adult male athletes long after (18-20 hours) a rugby union match.

Study Type

Interventional

Enrollment (Actual)

26

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Parma, Italy
        • Collegio Italiano di Osteopatia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • being healthy and injury-free
  • age ≥ 18 years old
  • being Caucasian
  • regular participation in competitive matches of rugby union consisting of 2, 40-min halves
  • regular training for an average of six hours/week during the last four weeks

Exclusion Criteria:

  • history of cardiovascular disease or traumatic brain injury
  • chronic drug treatment
  • use of any medications during the last week
  • having received osteopathic manipulative treatment before

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
OTHER: AFTER MATCH + OMT
Players undertook a recording session the day after a rugby match and received osteopathic manipulative treatment
Each osteopathic manipulative treatment consisted of a structured evaluation to diagnose somatic dysfunction of the pelvis, abdomen, vertebral spine, and upper and lower limbs (10 min), followed by the therapeutic application of manually guided forces to improve physiological function and homeostasis that has been altered by somatic dysfunction for 20 min, using techniques that were left at the discretion of the osteopath, including the myofascial release and cranial sacrum techniques
OTHER: AFTER MATCH + sham treatment
Players undertook a recording session the day after a rugby match and received sham treatment
The sham treatment consisted only in "soft touch" of the same body areas involved in the osteopathic manipulative treatment protocol without applying any pressure
OTHER: NO MATCH + OMT
Players undertook a recording session the day after a resting day and received osteopathic manipulative treatment
Each osteopathic manipulative treatment consisted of a structured evaluation to diagnose somatic dysfunction of the pelvis, abdomen, vertebral spine, and upper and lower limbs (10 min), followed by the therapeutic application of manually guided forces to improve physiological function and homeostasis that has been altered by somatic dysfunction for 20 min, using techniques that were left at the discretion of the osteopath, including the myofascial release and cranial sacrum techniques
OTHER: NO MATCH + sham treatment
Players undertook a recording session the day after a resting day and received sham treatment
The sham treatment consisted only in "soft touch" of the same body areas involved in the osteopathic manipulative treatment protocol without applying any pressure

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Resting heart rate
Time Frame: ECG recorded for 10 min just before osteopathic manipulative treatment and sham treatment
Mean heart rate measured as beats per minute
ECG recorded for 10 min just before osteopathic manipulative treatment and sham treatment
Resting heart rate
Time Frame: ECG recorded for 5 min just after osteopathic manipulative treatment and sham treatment
Mean heart rate measured as beats per minute
ECG recorded for 5 min just after osteopathic manipulative treatment and sham treatment
Resting heart rate variability (RMSSD index)
Time Frame: ECG recorded for 10 min just before osteopathic manipulative treatment and sham treatment
Root mean square of the successive differences between adjacent heart beats (RMSSD) measured in ms
ECG recorded for 10 min just before osteopathic manipulative treatment and sham treatment
Resting heart rate variability (RMSSD index)
Time Frame: ECG recorded for 5 min just after osteopathic manipulative treatment and sham treatment
Root mean square of the successive differences between adjacent heart beats (RMSSD) measured in ms
ECG recorded for 5 min just after osteopathic manipulative treatment and sham treatment
Resting heart rate variability (HF index)
Time Frame: ECG recorded for 10 min just before osteopathic manipulative treatment and sham treatment
High frequency (HF) component power of the RR interval spectrum measured in ms2
ECG recorded for 10 min just before osteopathic manipulative treatment and sham treatment
Resting heart rate variability (HF index)
Time Frame: ECG recorded for 5 min just after osteopathic manipulative treatment and sham treatment
High frequency (HF) component power of the RR interval spectrum measured in ms2
ECG recorded for 5 min just after osteopathic manipulative treatment and sham treatment
Resting mean arterial pressure
Time Frame: Assessed just before osteopathic manipulative treatment and sham treatment with a sphygmomanometer
Mean arterial pressure measured in mmHg
Assessed just before osteopathic manipulative treatment and sham treatment with a sphygmomanometer
Resting mean arterial pressure
Time Frame: Assessed just after osteopathic manipulative treatment and sham treatment with a sphygmomanometer
Mean arterial pressure measured in mmHg
Assessed just after osteopathic manipulative treatment and sham treatment with a sphygmomanometer

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart rate reactivity to orthostasis
Time Frame: ECG recorded for 10 min during orthostasis (5 min) and subsequent recovery (5 min)
Mean heart rate measured as beats per minute
ECG recorded for 10 min during orthostasis (5 min) and subsequent recovery (5 min)
Heart rate variability (RMSSD index) reactivity to orthostasis
Time Frame: ECG recorded for 10 min during orthostasis (5 min) and subsequent recovery (5 min)
Root mean square of the successive differences between adjacent heart beats measured in ms
ECG recorded for 10 min during orthostasis (5 min) and subsequent recovery (5 min)
Heart rate variability (HF index) reactivity to orthostasis
Time Frame: ECG recorded for 10 min during orthostasis (5 min) and subsequent recovery (5 min)
High frequency component power of the RR interval spectrum measured in ms2
ECG recorded for 10 min during orthostasis (5 min) and subsequent recovery (5 min)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 1, 2017

Primary Completion (ACTUAL)

May 1, 2018

Study Completion (ACTUAL)

May 1, 2018

Study Registration Dates

First Submitted

January 21, 2020

First Submitted That Met QC Criteria

January 22, 2020

First Posted (ACTUAL)

January 27, 2020

Study Record Updates

Last Update Posted (ACTUAL)

January 27, 2020

Last Update Submitted That Met QC Criteria

January 22, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Physiological Phenomena

Clinical Trials on Osteopathic manipulative treatment

3
Subscribe